Improving Models of Care for Diabetes in Pregnancy: Experience of Current Practice in Far North Queensland, Australia

Frontiers in Public Health
Anna McLeanL Maple-Brown

Abstract

Aims: To map health practitioners' experiences and describe knowledge regarding screening and management of Diabetes in Pregnancy (DIP) in Far North Queensland, Australia. Methods: Mixed methods including a cross-sectional survey (101 respondents) and 8 focus groups with 61 health practitioners. All participants provided clinical care for women with DIP. Results: A wide range of healthcare professionals participated; 96% worked with Indigenous women, and 63% were from regional or remote work settings. Universal screening for gestational diabetes at 24-28 weeks gestation was reported as routine with 87% using a 75 g Oral Glucose Tolerance Test. Early screening for DIP was reported by 61% although there was large variation in screening methods and who should be screened <24 weeks. Health practitioners were confident providing lifestyle advice (88%), dietary, and blood glucose monitoring education (67%, 81%) but only 50% were confident giving insulin education. Electronic medical records were used by 80% but 55% also used paper records. Dissatisfaction with information from hospitals was reported by 40%. In the focus groups improving communication and information technology systems were identified as key areas. Other barriers desc...Continue Reading

References

Aug 23, 2003·BMJ : British Medical Journal·Robyn McDermottAshim Sinha
Jun 14, 2005·The New England Journal of Medicine·Caroline A CrowtherUNKNOWN Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group
Jun 5, 2010·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Henrik FalhammarAshim K Sinha
Aug 6, 2010·The Journal of Clinical Endocrinology and Metabolism·Jennifer Hone, Lois Jovanovic
Aug 25, 2012·Diabetes Research and Clinical Practice·Cynthia PorterIsabelle Ellis
Mar 12, 2013·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Bronwyn DavisHenrik Falhammar
Dec 3, 2013·BMC Pregnancy and Childbirth·Louise J Maple-BrownKerin O'Dea
Oct 14, 2014·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Laura EdwardsUNKNOWN NT Diabetes in Pregnancy Partnership
Jul 2, 2015·World Journal of Diabetes·Victor DuongHenrik Falhammar
Aug 13, 2015·Diabetes Research and Clinical Practice·Tshepo M RasekabaKwang Lim
Dec 28, 2016·The Journal of Obstetrics and Gynaecology Research·Ram UmaViswanathan Mohan
Aug 5, 2017·BMC Health Services Research·R KirkhamUNKNOWN NT Diabetes in Pregnancy Partnership
Aug 5, 2017·PloS One·Renae KirkhamUNKNOWN Northern Territory Diabetes in Pregnancy Partnership
Aug 24, 2017·Diabetes, Obesity & Metabolism·Kamlesh KhuntiJesús Medina
Aug 29, 2017·American Journal of Obstetrics and Gynecology·Kathryn M McKenneyLynn M Yee
Oct 24, 2017·Primary Health Care Research & Development·Sandra CampbellCatherine Chamberlain

❮ Previous
Next ❯

Citations

Jan 26, 2020·International Journal of Environmental Research and Public Health·Anna WoodLouise Maple-Brown
Sep 2, 2020·BMC Health Services Research·D MacKayUNKNOWN Diabetes Across the Lifecourse: Northern Australia Partnership
Jul 20, 2021·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Judith Dyson, Fiona Cowdell
Aug 1, 2021·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Diana MacKayUNKNOWN Diabetes Across the Lifecourse: Northern Australia Partnership

❮ Previous
Next ❯

Software Mentioned

FNQ
NVivo QSR
Stata
Survey Monkey
DIPPINQ

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Ernest HunterGeraldine Dyer
The Australian & New Zealand Journal of Obstetrics & Gynaecology
Joyce LeungCaroline de Costa
© 2021 Meta ULC. All rights reserved